• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX; BIFURCATED STENT GRAFT Back to Search Results
Model Number BA25-90/I16-30
Device Problems Failure To Adhere Or Bond (1031); Leak/Splash (1354); Stretched (1601); Unintended Movement (3026)
Patient Problems Aneurysm (1708); Failure of Implant (1924)
Event Date 03/08/2018
Event Type  Injury  
Manufacturer Narrative
The devices involved in the event will not be returned for evaluation, they remain implanted in the patient.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
An afx bifurcated and a suprarenal extension was implanted to treat an abdominal aortic aneurysm.The 5 year follow-up showed the presence of an endoleak and aneurysm enlargement; however, the type of endoleak cannot be determined at this time but the patient had minimal overlap and proximal neck dilation with dilation of the proximal cuff.Patient is currently reported to be doing well.The physician will evaluation the patient for further treatment.
 
Manufacturer Narrative
Based on the information received, clinical evaluation confirmed the reported aneurysm enlargement.Clinical evaluation was unable to confirm the reported patient status of doing well and being on surveillance.Additionally, clinical evaluation found a type iiia -aortic endoleak with complete component separation.The most likely cause of the proximal and mid-aortic (complete component separation) loss of seal was the anterior remodeling of the aorta; however, a definitive root cause cannot be determined.There was no evidence of a secondary procedure and the patient status is unknown.Reportedly, the patient will be on surveillance.There are no further reports of negative patient sequelae.The devices remain implanted in the patient and will not be returned; therefore, device evaluation will not be completed.The review of manufacturing lot confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
Manufacturer Contact
victor arellano
2 musick
irvine, CA 92618
9495984671
MDR Report Key7403429
MDR Text Key104591739
Report Number2031527-2018-00219
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date01/31/2013
Device Model NumberBA25-90/I16-30
Device Lot Number1031315-003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/08/2018
Initial Date FDA Received04/06/2018
Supplement Dates Manufacturer Received05/22/2018
Supplement Dates FDA Received06/19/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured03/13/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AFX-SUPRARENAL-LOT: W11-4192-016
Patient Outcome(s) Other;
Patient Age79 YR
-
-